GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 165 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $2,013,000 | +202.3% | 137,905 | +193.9% | 0.00% | – |
Q3 2020 | $666,000 | -91.9% | 46,916 | -95.5% | 0.00% | -100.0% |
Q3 2015 | $8,220,000 | -99.9% | 1,044,430 | -2.9% | 0.01% | 0.0% |
Q2 2015 | $9,748,551,000 | -31.6% | 1,075,999 | -2.0% | 0.01% | -28.6% |
Q1 2015 | $14,244,460,000 | -1.9% | 1,097,416 | +2.8% | 0.01% | 0.0% |
Q4 2014 | $14,522,346,000 | +65508.1% | 1,067,035 | -56.8% | 0.01% | -41.7% |
Q3 2014 | $22,135,000 | -33.2% | 2,467,611 | +0.7% | 0.01% | -29.4% |
Q2 2014 | $33,140,000 | -99.8% | 2,449,386 | +21.0% | 0.02% | +54.5% |
Q1 2014 | $20,119,256,000 | -19.1% | 2,024,070 | +8.1% | 0.01% | -21.4% |
Q4 2013 | $24,877,684,000 | +8.8% | 1,871,910 | -0.6% | 0.01% | 0.0% |
Q3 2013 | $22,861,926,000 | +83.9% | 1,883,190 | +56.8% | 0.01% | +75.0% |
Q2 2013 | $12,431,880,000 | – | 1,201,380 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 2,730,000 | $11,384,000 | 2.77% |
CADIAN CAPITAL MANAGEMENT, LP | 5,017,483 | $20,923,000 | 1.28% |
Ghost Tree Capital, LLC | 500,000 | $2,085,000 | 0.49% |
Bellevue Group AG | 773,677 | $3,226,000 | 0.34% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 180,000 | $750,000 | 0.20% |
Penn Capital Management Company, LLC | 543,715 | $2,267,000 | 0.16% |
HighTower Advisors, LLC | 2,355,942 | $9,826,000 | 0.08% |
Granite Investment Partners, LLC | 215,760 | $900,000 | 0.06% |
WRAPMANAGER INC | 39,547 | $165,000 | 0.05% |
Alyeska Investment Group, L.P. | 1,563,881 | $6,521,000 | 0.05% |